Validation of the 8th edition of the American Joint Committee on Cancer Pathological Prognostic Staging for young breast cancer patients
Open Access
- 30 April 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (8), 7549-7560
- https://doi.org/10.18632/aging.103111
Abstract
Purpose: This study aimed to validate the newly proposed American Joint Committee on Cancer (AJCC) pathological prognostic staging system for young breast cancer patients (aged <= 40 years). Results: We included 12811 women in this study. Overall, 52.8% of patients in the 7th AJCC stages were restaged to the 8th AJCC pathological staging system, including 10.7% upstaged and 42.1% downstaged. The receiver operating characteristics analysis showed that the new staging system had a better role in predicting breast cancer-specific survival (BCSS) compared with 7th edition staging (P<0.001). The results of the multivariate prognostic analysis showed that the hazard ratio of BCSS increased with the 8th AJCC stages, while the 7th anatomic stages had no significant difference in BCSS. Conclusions: The novel pathological staging system could provide more accurate prognostic stratification for young women with breast cancer because of the high proportion of stage migration. Patients and Methods: Data for young breast cancer patients diagnosed between 2010 and 2014 were included from the Surveillance, Epidemiology, and End Results program. Chi-squared test, Kaplan-Meier method, receiver operating characteristics curve, and Cox proportional hazard analysis were applied to statistical analysis.Keywords
This publication has 38 references indexed in Scilit:
- A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard modelsEpidemiology and Health, 2017
- How Young Is Too Young in Breast Cancer?—Young Breast Cancer Is Not a Unique Biological SubtypeClinical Breast Cancer, 2017
- Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only StudyPLOS ONE, 2016
- Biology of breast cancer in young womenBreast Cancer Research, 2014
- Distinct Clinicopathological Features and Prognosis of Emerging Young-Female Breast Cancer in an East Asian Country: A Nationwide Cancer Registry-Based StudyThe Oncologist, 2014
- Breast Cancer in Adolescents and Young Adults: A Review With a Focus on BiologyJournal of the National Comprehensive Cancer Network, 2013
- Breast Carcinomas Arising at a Young Age: Unique Biology or a Surrogate for Aggressive Intrinsic Subtypes?Journal of Clinical Oncology, 2011
- Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancerJournal of Surgical Oncology, 2009
- Recent Trends in Breast Cancer Among Younger Women in the United StatesJNCI Journal of the National Cancer Institute, 2008
- Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Five National Surgical Adjuvant Breast and Bowel Project Node-Positive Adjuvant Breast Cancer TrialsJournal of Clinical Oncology, 2006